Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke


Phase 3 Results N/A

Summary of Purpose

This is a 3-arm, prospective, randomized, double-blind, and controlled clinical study, with 3 months of treatment to evaluate efficacy of DLBS1033 in bleeding profile and clinical outcome in patients with acute ischemic stroke compared with aspirin and clopidogrel, as active controls.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 June 2014.

1 May 2012 12 Feb 2013 1 Nov 2013 1 Dec 2013 1 Jan 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment